Associate Professor, Medicine, UCSF School of Medicine
Rheumatology
Dr. Mary C. Nakamura, MD
|
|
Give Review
Mary Nakamura practices Rheumatology. She studied medicine at Yale University School of Medicine. Yale University School of Medicine is one of the top medical schools in the US. Yale University School of Medicine is ranked 7 in research and 57 in primary care medicine She received 1 awards: "Fellow". Mary Nakamura is also a published doctor. She has 21 paper published. The most recent paper is: Ly-49A, a receptor for H-2Dd, has a functional carbohydrate recognition domain.
Publications
- A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.
- Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Deficiency Attenuates Phagocytic Activities of Microglia and Exacerbates Ischemic Damage in Experimental Stroke.
- CCR2 deficiency impairs macrophage infiltration and improves cognitive function after traumatic brain injury.
- Bone and the innate immune system.
- CIITA: A Master Regulator of Adaptive Immunity Shows its Innate Side in the Bone.
- Triggering Receptor Expressed on Myeloid Cells-2 Correlates to Hypothermic Neuroprotection in Ischemic Stroke.
- Traumatic brain injury induces macrophage subsets in the brain.
- Inflammatory Arthritis increases mouse osteoclast precursors with myeloid suppressor function.
- PSTPIP2 deficiency in mice causes Osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts.
- Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloArthritis.
- TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis.
- Mice lacking the integrin beta5 subunit have accelerated osteoclast maturation and increased activity in the estrogen-deficient state.
- The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase.
- The signaling adapter protein DAP12 regulates multinucleation during osteoclast development.
- CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation.
- A receptor for vascular endothelial growth factor that stimulates endothelial apoptosis.
- Ligand interactions by activating and inhibitory Ly-49 receptors.
- Ly-49A, a receptor for H-2Dd, has a functional carbohydrate recognition domain.
- Contemporary concepts of autoimmunity and autoimmune Diseases.
- Migration of IgA-bearing lymphocytes into salivary glands.
Schools
Yale University
Uc San Francisco
Johns Hopkins University
Procedures Preformed
- Joint Drainage
Conditions Treated
- Arthritis
- Bursitis
- Calcium Pyrophosphate Dihydrate Deposition Disease (CPPD)
- Carpal Tunnel Syndrome
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- Fellow
Education
-
Johns Hopkins Bloomberg School of Public Health -
UCSF -
Yale University School of Medicine
Hospital
-
San Francisco General Hospital and Trauma Center -
San Francisco VA Medical Center -
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. James A. Davis, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John B. Imboden Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary K. Connolly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Urmila Bajpai, MD |
|
|
Dr. William E. Seaman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kerstin Morehead, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Gross, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John C. Davis Jr., MD |
|
|
Dr. Stephen H. Nimelstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jinoos Yazdany, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. David Wofsy, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jonathan D. Graf, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ruth W. Chan, DO |
|
|
Dr. Matthew D. Cascino, MD
This Doctor is OpenDoctor Recommended.
|